Drug intelligence / Profile preview

AFDICAL Advance

Development stage
Unknown
Lead developer
Anglo-French Drugs & Industries
Modality
Small Molecules
Administration
Oral
01

Overview

AFDICAL Advance is a multi-ingredient bone health supplement developed and marketed by Anglo-French Drugs & Industries. It is formulated as a combination of calcium carbonate, vitamin D3 (cholecalciferol), and essential minerals including magnesium oxide and zinc sulfate. The product is designed to support bone mineral density, prevent osteoporosis, and address nutritional deficiencies in calcium and vitamin D. It functions by providing the structural components necessary for bone mineralization and enhancing the intestinal absorption of calcium through the activation of the vitamin D receptor. As a nutraceutical and over-the-counter (OTC) pharmaceutical product, it is primarily used for the maintenance of skeletal integrity and the prevention of bone-related disorders.

Brand names
AFDICAL Advance
02

Targets

VDR (Vitamin D receptor)HydroxyapatiteVKORC1/GGCX (Vitamin K cycle enzymes (Gamma-glutamyl carboxylase and Vitamin K epoxide reductase))

Beyond the preview

Go deeper on AFDICAL Advance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AFDICAL Advance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call